MARLVEL

iPacemaker Device vs its rivals

Side-by-side comparison against iPacemaker Device's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

iPacemaker Device
This App
UpToDate
Nemesis
Calculate by QxMD
Contender
PulsePoint Respond
Peer
ECG Guide
Peer
Doximity
Peer
Kardia
Peer
Vargo Anesthesia Mega App
New Kid
Core Identity
DeveloperIPACEMAKER S.R.L.UpToDate, Inc.WebMDPulsePoint FoundationWebMDDoximityAliveCor, Inc.Vargo Anesthesia Inc
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformiOS, AndroidAndroid, iOSiOS, AndroidiOS, AndroidiOS, AndroidAndroid, iOSiOS, AndroidAndroid, iOS
Store Metrics
Rating4.7 / 53.7 / 54.8 / 54.8 / 53.6 / 54.8 / 54.8 / 54.7 / 5
Ratings Count3475285,086258,5348191,451210,895158
PriceFreeFreeFreeFree$0.99FreeFree$99.99
Release DateJun 25, 2016Apr 15, 2011Mar 20, 2010Feb 13, 2012Dec 31, 2008Sep 29, 2010Jan 6, 2013Jan 9, 2014
Last UpdatedApr 16, 2026Feb 24, 2026Dec 19, 2025Apr 7, 2026Jan 30, 2019Apr 17, 2026Apr 15, 2026Mar 19, 2026
Sentiment & Reviews
Sentimentnegativeterrible------
Score25/10015/100------
Praises
  • Extensive device information serves as a reliable reference tool for cardiac rhythm specialists
  • High quality clinical content remains the primary reason for long-term professional reliance
------
Complaints
  • Subscription model implementation restricts access to previously purchased content for long-term users
  • Persistent application freezing during search and article loading renders the tool unusable
------
Requests-
  • Concise article summaries with optional links for atomic level detail
------
Strategic Intel
Strengths
  • Proprietary MRI-compatibility engine creates high switching costs
  • 7,000-device database functions as a B2B reference standard
  • Clinician-authored content functions as a high-switching-cost brand moat
  • Expert AI integration provides a premium-tier conversion lever
-----
  • Niche specialization in anesthesia workflows
  • Offline-first architecture for OR environments
  • One-time purchase model vs. subscriptions
Weaknesses
  • Subscription transition alienated legacy users
  • Database staleness regarding new hardware
  • Mandatory disclaimer friction
  • Persistent search-result freezing drives high churn risk
  • Offline mode failure prevents access in remote clinical settings
-----
  • High $99.99 upfront cost barrier
  • Static content updates vs. weekly evidence feeds
  • Lack of automated drug dose calculations
Pricingfreemiumsubscriptionfreefreefreefreefreemiumpaid
MomentumIntenseActiveSteadyIntenseSteadyIntenseIntenseMaintenance
Update Cadence3 versions5 versions5 versions5 versions5 versions5 versions5 versions5 versions, ~18d avg

Compare iPacemaker Device head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by iPacemaker Device, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

See methodologyContact support

Data licensed under CC-BY-NC 4.0